Randomized single-dose crossover comparative bioavailability study of two novel oral cannabidiol (CBD) formulations in healthy volunteers under fed conditions, compared to a standard CBD isolate capsule.

J Cannabis Res · 2025 · PMC12330118 · PMID 40770387

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantp < 0.001actually significant

In both cases, the lower bound of the 90% CI was well above 125%, confirming a highly significant increase ( p < 0.001) in CBD exposure with the enhanced capsule.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.